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Background: Genome-scale metabolic models are important tools in systems biology. They permit the in-silico
prediction of cellular phenotypes via mathematical optimisation procedures, most importantly flux balance analysis.
Current studies on metabolic models mostly consider reaction fluxes in isolation. Based on a recently proposed
metabolite-centric approach, we here describe a set of methods that enable the analysis and interpretation of flux
distributions in an integrated metabolite-centric view. We demonstrate how this framework can be used for the
refinement of genome-scale metabolic models.
Results: We applied the metabolite-centric view developed here to the most recent metabolic reconstruction of
Escherichia coli. By compiling the balance sheets of a small number of currency metabolites, we were able to fully
characterise the energy metabolism as predicted by the model and to identify a possibility for model refinement in
NADPH metabolism. Selected branch points were examined in detail in order to demonstrate how a metabolite-centric
view allows identifying functional roles of metabolites. Fructose 6-phosphate aldolase and the sedoheptulose
bisphosphate bypass were identified as enzymatic reactions that can carry high fluxes in the model but are unlikely to
exhibit significant activity in vivo. Performing a metabolite essentiality analysis, unconstrained import and export of iron
ions could be identified as potentially problematic for the quality of model predictions.
Conclusions: The system-wide analysis of split ratios and branch points allows a much deeper insight into the
metabolic network than reaction-centric analyses. Extending an earlier metabolite-centric approach, the methods
introduced here establish an integrated metabolite-centric framework for the interpretation of flux distributions in
genome-scale metabolic networks that can complement the classical reaction-centric framework. Analysing fluxes and
their metabolic context simultaneously opens the door to systems biological interpretations that are not apparent from
isolated reaction fluxes. Particularly powerful demonstrations of this are the analyses of the complete metabolic
contexts of energy metabolism and the folate-dependent one-carbon pool presented in this work. Finally, a
metabolite-centric view on flux distributions can guide the refinement of metabolic reconstructions for specific growth
scenarios.
Keywords: Split ratios, Branch points, Metabolic modelling, Flux balance analysis, Metabolic reconstruction, Constraint-
based modelling, Stoichiometric matrix, Linear programming, iJO1366, iAF1260Background
The advent of rapid sequencing technologies, the collec-
tion and sharing of omics data in electronic databases, and
the development of a wealth of computational tools in sys-
tems biology have allowed the reconstruction of metabolic
networks on a genome-wide scale. Since the first whole-
genome metabolic model was published in 1999 [1], the* Correspondence: d.schomburg@tu-bs.de
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reproduction in any medium, provided the ornumber of genome-scale metabolic reconstructions has
been growing steadily, and a recent review lists metabolic
reconstructions for more than sixty organisms [2].
Whole-genome metabolic models play a dual role in sys-
tems biology: Firstly, they are structured knowledge bases
that integrate data about the metabolism of the modelled
organism from a wide variety of sources, including data-
bases, primary literature, and expert knowledge [3]. Sec-
ondly, they can be used to predict cellular phenotypes,
which allows, inter alia, the in-silico prediction of the ef-
fects of genetic or regulatory modifications or growth inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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are useful tools for generating hypotheses to guide wet-lab
experiments and for providing context for the interpret-
ation of experimental data. In addition, metabolic models
are needed for metabolic engineering, the directed modifi-
cation of the organism with respect to a metabolic goal
such as overproduction and export of some industrially
relevant chemical compound [5].
Escherichia coli is by far the best-studied prokaryote
and an important model organism in biology. Its metab-
olism is particularly well understood, and many enzymes
and biochemical pathways were first described in E. coli
(e.g. [6-9]). The latest whole-genome metabolic recon-
struction of E. coli K-12 MG1655, designated iJO1366
[10], is one of the most comprehensive genome-scale
metabolic models available. It is an extension of the earl-
ier models iAF1260 [11] and iJR904 [12].
Flux balance analysis and related methods for the ana-
lysis of whole-genome metabolic models produce a vector
of reaction fluxes. These are usually either given as abso-
lute values in mmol gDW−1 h−1 or as percentage of the
substrate uptake rate. Such values are, however, very hard
to interpret. For instance, what does it mean if the flux
from 2-oxoglutarate to L-glutamate via glutamate de-
hydrogenase is 6.3 mmol gDW−1 h−1? Or that the rate of
aspartate formation via aspartate transaminase is 22% of
the glucose uptake rate?
All genome-scale metabolic models published to date
are stoichiometric models, which incorporate reaction
stoichiometry but do not require any knowledge of kin-
etic parameters. While they do not allow the analysis of
non-equilibrium dynamics, stoichiometric models have
been found very useful for predicting the metabolic cap-
abilities in steady state [12-15].
Flux balance analysis (FBA) was introduced in 1986
[16], more than a decade before the first genome-scale
metabolic reconstruction, and has become the most com-
monly used method for predicting steady-state fluxes in
metabolic networks. Its core idea is the assumption that
wild-type organisms have been optimised through the
course of their evolution [17], e.g. for rapid or efficient
growth.
Oberhardt et al. [4] list the following major goals com-
monly pursued in analyses of whole-genome metabolic re-
constructions: (1) Contextualisation of high-throughput
data, (2) guidance of metabolic engineering, (3) directing
hypothesis-driven discovery, (4) interrogation of multi-
species relationships, and (5) network property discovery.
Analyses pertaining to all of these goals are currently
performed chiefly in a reaction-centric framework.
Contextualisation of high-throughput data is achieved
by adding constraints to the model or modifying existing
constraints [4]. Usually, these changes only pertain to iso-
lated reaction fluxes. For instance, both a gene knockoutand the regulatory suppression of a gene product are mod-
elled by constraining the flux through all reactions catalysed
by the gene product to zero [18]. Of particular importance
are gene expression data, which are also usually incorpo-
rated in the form of constraints on individual reaction
fluxes [19-22]. Furthermore, rapid phenotyping data (such
as from BIOLOG phenotype microarrays) are employed in
the form of binary variables (growth/ no growth on a par-
ticular substrate) [15,23].
While the performance of models may initially be
analysed in terms of growth rate and efficiency, the most
specific tool for the validation of metabolic models is the
comparison of predicted flux distributions to experimen-
tally determined fluxes, usually obtained via 13C-labeling
experiments [11,24]. Due to the lower concentrations of
metabolites in peripheral pathways, this method is limited
to fluxes in or close to central carbon metabolism [25-27].
Model-based metabolic engineering also employs a
reaction-centric view. The most commonly used ap-
proaches try to modify individual reaction fluxes to re-
direct metabolic flux or to find a combination of gene
knockouts leading to overproduction of the desired me-
tabolite [28-31].
A first metabolite-centric approach for the analysis of
genome-scale metabolic models was introduced in 2007
[32] and expanded in 2009 [33]. This approach, termed
flux-sum analysis, has been employed successfully for the
prediction of metabolite essentiality and for studying the
robustness of metabolic networks to perturbations in me-
tabolite turnover rates. To our knowledge, its application
has so far been limited to the study of network robustness,
either as a fundamental network property [33] or with the
specific goal of identifying novel drug targets [34].
The concept of branch points and flux split ratios has
been used in wet-lab metabolic flux analysis using small-
scale metabolic models [35-37], particularly in the context
of metabolic engineering projects [38-40]. There also exist
implementations of FBA that explicitly support linear con-
straints defined in terms of split ratios [41,42]. However,
to our knowledge, this concept has never been applied sys-
tematically for the analysis of the (predicted) flux distribu-
tion in a whole-genome metabolic reconstruction.
Here we show that the system-wide analysis of split ra-
tios and branch points, leading to a metabolite-centric
view on flux distributions, allows a much deeper insight
into the metabolic network based on the results of flux
balance analysis. For this purpose, we introduce a set of
methods that generate a metabolite-centric description
based on a given flux distribution. Moreover, we demon-
strate how a system-wide analysis of metabolite essenti-
ality, which is only possible within a metabolite-centric
framework, can identify potential problems in a network
reconstruction. We further show how, e.g., energy me-
tabolism can be characterised by examining the flux split
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also demonstrate how a metabolite-centric view can be
used for the refinement of models against experimental
data, in particular by identifying enzymatic reactions not
known to occur in vivo or known for very specific sce-
narios only, i.e. reactions or enzymes whose presence in
the model may lower the quality of the model’s predic-
tions in some, possibly most, scenarios.
Results
FBA was performed for the chosen scenario, carbon-
limited aerobic growth in glucose minimal medium with
forced acetate secretion (see Methods section), with the
following constraints: Glucose uptake was limited to a rate
of at most 11.0 mmol gDW−1 h−1, and a lower bound of
6.4 mmol gDW−1 h−1 was imposed on the acetate export
flux. For this scenario, FBA predicted a growth rate of
0.85 h−1, an oxygen uptake rate of 16.5 mmol gDW−1 h−1,
and a CO2 emission rate of 18.2 mmol gDW
−1 h−1. In the
FBA solution, only 552 of the 2583 reactions (21%) involv-
ing 557 of the 1805 metabolites (31%) are active (at a cutoff
of 10−12 mmol gDW−1 h−1). Of the 557 active metabolites,
401 are part of unbranched paths, i.e. they are each pro-
duced via a single reaction and consumed via another sin-
gle reaction. These metabolites are purely transitory in the
scenario under consideration. Consequently, only the
remaining 156 metabolites (8.6% of all metabolite nodes or
28% of the active metabolites) are branch points, where
fluxes split or join.
Balance sheets of currency metabolites
Split-ratio analysis was used to explore the fate of currency
metabolites, most importantly energy-rich phosphates
(such as ATP, GTP, and phosphoenolpyruvate (PEP)) and
reducing equivalents (chiefly NADH and NADPH).
ATP
Table 1 lists the relative contributions of reactions pro-
ducing ATP. The total flux through ATP is 69.7 mmol
gDW−1 h−1, which has to be corrected for salvage reac-
tions, such as for diphosphate, which regenerate some
“spent” ATP. This correction yields an ATP production
rate of 66.9 mmol gDW−1 h−1, i.e. the net yield is 6.1Table 1 Split ratios of ATP-producing fluxes
Producing fluxes
Reaction/Enzyme Pathway/Product Ratio
ATP synthase oxidative phosphorylation 61.35%
phosphoglycerate kinase glycolysis 25.47%
acetate kinase acetate export 8.46%
polyphosphate kinase ADP + diphosphate 4.02%
succinyl-CoA synthetase TCA cycle 0.71%
Total flux: 69.7 mmol gDW−1 h−1. Ratios below 0.05% not shown.molecules of ATP per glucose molecule. The largest part
(61.4% of the total ATP flux) is produced via oxidative
phosphorylation. 25.5% is produced in glycolysis, while
8.5% is produced in the conversion of acetyl-CoA to
acetate, which is excreted. While 4.0% of the total pro-
ducing ATP flux stems from the reaction of ADP with
diphosphate, only 0.7% is produced in the TCA cycle.
The ratios of ATP-consuming fluxes are shown in
Table 2. Most of the ATP is consumed in the biomass re-
action as growth-associated maintenance requirement
(GAM; see Methods) (66.2%), fuelling growth-related pro-
cesses. The second largest fraction is glycolysis, which
consumes 8.8% and thus has an overall positive ATP bal-
ance. 6.2% is used in the biosynthesis of L-amino acids,
one-third of which is accounted for by L-glutamine alone
(2.1% of the ATP flux), followed by L-threonine (1.3%)
and L-arginine (1.1%). The non-growth associated main-
tenance requirement (NGAM; see Methods) accounts for
4.5% of the total ATP consumption, purine metabolism
consumes 3.4%, and 2.7% is used for the (re)phosphoryl-
ation of AMP to ADP. Another 2.7% is consumed in fatty
acid biosynthesis, while 1.6% is converted to the other nu-
cleoside triphosphates GTP (0.9%), UTP (0.5%), and CTP
(0.2%). 1.2% of the ATP is spent in pyrimidine metabolism,
and 1.1% is used in the pentose phosphate pathway for the
production of phosphoribosyl pyrophosphate, while an-
other 0.6% is consumed in sulfate assimilation. 0.2% of the
total ATP enters the biomass directly. The rest is used in
the biosynthesis of other biomass components, including
cell wall components (peptidoglycans), deoxyribonucleoside
triphosphates, glycogen, lipopolysaccharides, phospholipids,
and various cofactors.
The fluxes through the other nucleoside triphosphates
are low (GTP: 0.64, UTP: 0.34, CTP: 0.25 mmol gDW−1
h−1), and their contributions to energy metabolism are
not substantial compared to those of ATP and PEP.
Phosphoenolpyruvate (PEP)
The split ratios for PEP are shown in Table 3. The total
flux through PEP is 16.3 mmol gDW−1 h−1. As expected,
PEP is produced entirely in glycolysis via the enolase reac-
tion. 67.5% of the PEP is used by the phosphotransferase
system for glucose import and phosphorylation, yielding
pyruvate as the second product. 15.4% is consumed in the
anaplerotic reaction catalysed by PEP carboxylase, while
13.0% is used for phosphorylating dihydroxyacetone to di-
hydroxyacetone phosphate. Another 3.9% is consumed in
two reactions in the shikimate pathway, which produces
the precursors of the aromatic amino acids. Small quan-
tities of PEP are consumed in the pathways producing
peptidoglycans (0.14%) and lipopolysaccharides (0.13%).
The large flux through dihydroxyacetone (DHA) kinase
is unexpected, as DHA is not known as an intracellular
metabolite in E. coli except as a usable carbon source [43]
Table 2 Split ratios of ATP-consuming fluxes
Consuming fluxes
Reaction/Enzyme Pathway/Product Ratio
Biomass (incl. GAM) 66.39%
phosphofructokinase glycolysis 8.77%
ATP maintenance requirement NGAM 4.52%
adenylate kinase AMP→ADP 2.73%
acetyl-CoA carboxylase fatty acids 2.68%
AICAR biosynthesis from PRPP
(5 reactions)
purines 2.67%
glutamine synthetase Gln 2.13%
aspartate kinase Thr, Met, Lys, peptidoglycans 1.28%
PRPP synthetase pentose phosphate pathway 1.11%
nucleoside-diphosphate kinase GTP 0.92%
carbamate kinase pyrimidines, Arg, polyamines 0.75%
homoserine kinase Thr 0.65%
nucleoside-diphosphate kinase UTP 0.49%
shikimate kinase shikimate pathway 0.46%
UMP kinase pyrimidines 0.44%
acetylglutamate kinase Arg, polyamines 0.40%
argininosuccinate synthase Arg 0.35%
adenylyl-sulfate kinase sulfur metabolism 0.30%
sulfate adenyltransferase sulfur metabolism 0.30%
guanylate kinase purines 0.29%
GMP synthase purines 0.29%
asparagine synthetase Asn 0.29%
glutamate 5-kinase Pro 0.26%
cytidylate kinase pyrimidines 0.20%




nucleoside-diphosphate kinase CTP 0.17%
6 reactions in cell wall
biosynthesis
peptidoglycans 0.17%






ATP phosphoribosyltransferase His, purines 0.11%
Total flux: 69.7 mmol gDW−1 h−1. Ratios below 0.05% not shown.
Abbreviations: AICAR – 5-aminoimidazole-4-carboxamide ribotide, Arg, Asn, …
– biosynthesis of L-amino acids, PRPP – phosphoribosyl pyrophosphate.









PEP carboxylase anaplerotic reactions 15.35%








3-deoxy-8-phosphooctulonate synthase lipopolysaccharides 0.13%
Total flux: 16.3 mmol gDW−1 h−1. Ratios below 0.05% not shown.
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very low rate in this particular scenario (5.5 μmol gDW−1
h−1, FVA: 4–19 μmol gDW−1 h−1). In our FBA solution,
DHA is produced at a large rate (2.1 mmol gDW−1 h−1)
via fructose-6-phosphate (F6P) aldolase, which cleaves F6P
into glyceraldehyde 3-phosphate and DHA. FVA was used
to verify that activity in this reaction is not required foroptimum growth. If the flux through F6P aldolase is
constrained to the condensation direction (i.e. producing
F6P from glyceraldehyde 3-phosphate and DHA), all of
the glycolytic flux must go through either the fructose
bisphosphate aldolase reaction or the sedoheptulose
bisphosphate bypass (first described in [46]) in order to
achieve optimum growth.
By combining the balance sheets for ATP and PEP, it
is possible to compute the net balance of glycolysis: It
generates 1.6 molecules of ATP and 1.5 PEP per glucose
molecule, while consuming 0.6 ATP and 1.2 PEP, i.e. the
balance is positive with a net production of 1.1 ATP and
0.3 PEP per molecule of glucose. This corresponds to
67.4% of the theoretical maximum of 2 molecules of
ATP or PEP [47], i.e. one-third of the flux branches off
from glycolysis or the pentose phosphate pathway to
anabolic pathways producing biomass components.
NADH
Equally important to the energy balance of the cell are
the reducing equivalents NADH and NADPH. The cor-
responding balance sheets are shown in Tables 4 and 5.
The flux through NADH is 33.7 mmol gDW−1 h−1.
52.7% is produced in glycolysis, with another 32.1% gen-
erated in the formation of acetyl-CoA from pyruvate,
while only 8.1% is produced in the TCA cycle. 6.2% of
the NADH is generated as a byproduct of amino acid
biosynthesis pathways, while the rest is produced as a
byproduct of purine and folate metabolism, respectively.
Almost all of the NADH is used for energy metabolism:
94.5% enters the electron transport chain via NADH de-
hydrogenase. Most of the remaining NADH (5.1%) is
consumed in fatty acid biosynthesis, while 0.4% is used
in the biosynthesis of L-methionine. This is consistent
with the general observation that in bacteria grown






pyruvate dehydrogenase glycolysis/TCA cycle 32.14%
malate dehydrogenase TCA cycle 5.35%
phosphoglycerate dehydrogenase Ser 4.31%
2-oxoglutarate dehydrogenase TCA cycle 2.78%
3-isopropylmalate dehydrogenase Leu 1.11%
IMP dehydrogenase purines 0.60%
histidinol dehydrogenase His 0.47%
prephenate dehydrogenase Tyr 0.34%
glycine cleavage system folate metabolism 0.14%
Consuming fluxes
Reaction/Enzyme Pathway/Product Ratio







Total flux: 33.7 mmol gDW−1 h−1. Ratios below 0.05% not shown.
Abbreviations: His, Leu, … – biosynthesis of L-amino acids.
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the catabolic pathways of glycolysis and TCA cycle and
used almost exclusively for ATP generation [47].
NADPH
At 13.9 mmol gDW−1 h−1, the flux through NADPH is
59% lower than that through NADH. The largest part
(80.7%) stems from the oxidative pentose phosphate path-
way (PPP). Another 13.4% is produced by the enzyme
isocitrate dehydrogenase (ICD) in the TCA cycle, while
5.9% is generated as a byproduct in purine metabolism. It
has been shown in 13C tracer experiments that in E. coli
grown aerobically on glucose, 35–45% of the NADPH is
produced from NADH and NADP+ by the membrane-
bound proton-translocating transhydrogenase PntAB,
while another 35–45% is produced in the PPP, and 20–
25% is produced by ICD [48]. In contrast, FBA predicted
no transhydrogenase activity for the model, and FVA con-
firmed that under the constraint of maximum biomass
production, no significant transhydrogenase flux is pos-
sible. The prediction that malic enzyme does not play a
significant role for NADPH generation in the scenario
under consideration (confirmed by FVA) is in agreement
with the experimental observations [48].
An exploratory FBA in an alternative scenario with a
forced transhydrogenase flux of 5 mmol gDW−1 h−1 yielded
a flux distribution in agreement with the results of [48],
predicting 36% of the NADPH to be produced bytranshydrogenase, 21% by ICD, and 37% by the PPP. At
the same time, this FBA solution was slightly better at
predicting the oxygen uptake rate (16.7 vs. 16.5 mmol
gDW−1 h−1; experimental value: 18.2 ± 0.8 mmol gDW−1
h−1 [49]) than that obtained with the original parameters,
while predicting roughly the same values for growth rate
and CO2 emission rate.
Apart from being a biomass component itself, NADPH
is consumed in 33 reactions with a flux above 0.1 μmol
gDW−1 h−1. 77.8% is used for the biosynthesis of various
amino acids, of which two-thirds (51.7% of the total
NADPH) is accounted for by L-glutamate alone, followed
by L-threonine (6.5%) and L-lysine (4.1%). The biosyn-
theses of all three branched-chain amino acids together
consume 7.0% of the NADPH. Other major processes
consuming NADPH are fatty acid biosynthesis (13.4%)
and sulfur assimilation (4.6%). 2.1% is used for restoring
thioredoxin to the reduced state, which in turn is used for
sulfur assimilation (71%) and biosynthesis of deoxyribonu-
cleotides (29%). 1.0% of the NADPH is used in phospho-
lipid biosynthesis, while the remainder is consumed in the
biosynthesis of other biomass components, including
polyamines, peptidoglycans, lipopolysaccharides, and vari-
ous cofactors. 0.16% is consumed in folate metabolism.
Both the lower flux through NADPH compared to NADH
and the distribution of the NADPH-consuming flux over
a large number of reactions in various biosynthetic path-
ways are in good agreement with the paradigm that while
NADH is used for energy metabolism, NADPH acts,
among other functions, as a reducing agent in anabolic
pathways [47].
Selected branch points
A detailed analysis of the split ratios in selected metabolite
nodes was performed with the two goals of elucidating the
metabolic roles of metabolite species and identifying the
relative contributions of biochemical pathways to biomass
formation and energy generation, respectively, in the sce-
nario under consideration.
Table 6 shows the fluxes producing and consuming 2-
oxoglutarate. The total flux through the metabolite is 8.1
mmol gDW−1 h−1, of which 77.0% is generated as a
byproduct of various transaminases, which transfer the
amino group of L-glutamate to different acceptors, produ-
cing L-amino acids. In contrast, only 23.0% is produced de
novo from isocitrate in the TCA cycle. The consuming side
also reflects the presence of a transamination cycle: 88.5%
of the 2-oxoglutarate is converted to L-glutamate, while
only 11.5% is metabolised in the TCA cycle.
Subtracting the flux of 6.3 mmol gDW−1 h−1 going
through the transamination cycle yields a net balance, in
which 100% of the 2-oxoglutarate (1.9 mmol gDW−1 h−1) is
produced in the TCA cycle. Of this non-cyclic flux, 50.1%
continues in the TCA cycle, while 49.8% is converted to L-
Table 5 NADPH balance
Producing fluxes
Reaction/Enzyme Pathway/Product Ratio
glucose 6-phosphate dehydrogenase pentose phosphate pathway 40.35%
phosphogluconate dehydrogenase pentose phosphate pathway 40.35%
isocitrate dehydrogenase TCA cycle 13.40%
methylenetetrahydrofolate dehydrogenase purines 5.89%
Consuming fluxes
Reaction/Enzyme Pathway/Product Ratio
glutamate dehydrogenase Glu 51.65%
3-oxoacyl-[acyl-carrier-protein] reductase (11 reactions) fatty acids 13.41%
ketol-acid reductoisomerase (2 reactions) Val, Leu, Ile, coenzyme A 6.95%
aspartate semialdehyde dehydrogenase Thr, Met, Lys, peptidoglycans 6.43%
sulfite reductase sulfur metabolism 4.57%
homoserine dehydrogenase Thr, Met 4.21%
shikimate dehydrogenase shikimate pathway 2.28%
dihydrodipicolinate reductase Lys, peptidoglycans 2.22%
thioredoxin reductase conversions to other redox carriers 2.14%
N-acetyl-γ-glutamyl-phosphate reductase Arg, polyamines 2.01%
glutamate 5-semialdehyde dehydrogenase Pro 1.32%
pyrroline 5-carboxylate reductase Pro 1.32%
glycerol 3-phosphate dehydrogenase phospholipids 1.03%
UDP-N-acetylenolpyruvoylglucosamine reductase peptidoglycans 0.17%
dihydrofolate reductase folate metabolism 0.16%
dTDP-4-dehydrorhamnose reductase lipopolysaccharides 0.05%
Total flux: 13.9 mmol gDW−1 h−1. Ratios below 0.05% not shown.
Abbreviations: Arg, Glu, … – biosynthesis of L-amino acids.
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pathways.
A second transamination cycle exists between L-
glutamine as amino-group donor and L-glutamate. The
balance sheet for L-glutamate (Table 7) shows both trans-
amination cycles: Of the total flux of 8.5 mmol gDW−1 h−1
going through L-glutamate, 85.0% is produced from 2-
oxoglutarate, while 15.0% is the result of transamination
with L-glutamine as amino-group donor. 74.0% is used
for transferring amino groups, while 17.6% is converted to
L-glutamine.
The net balance of L-glutamate with all fluxes in the
two transamination cycles removed is shown in Table 8.
The remaining 0.93 mmol gDW−1 h−1, which are pro-
duced exclusively from 2-oxoglutarate, are chiefly used for
the biosynthesis of the amino acids L-arginine (26.4%), L-
glutamine (23.5%), and L-proline (19.8%), while another
23.5% enters the biomass directly. The rest is consumed in
the biosynthesis of polyamines (3.7%), peptidoglycans
(2.5%), and various cofactors.
Glucose 6-phosphate (G6P) is the first branch point
in glycolysis. It is shown in metabolic context (two levelsof depth) with split ratios in Figure 1. All G6P is gener-
ated from glucose via the phosphotransferase system,
which is both the main consumer of PEP and the main
producer of pyruvate. This illustrates how, in the scenario
under consideration, the phosphotransferase system ef-
fectively couples the first step of glycolysis (glucose uptake
and phosphorylation) with the last step (dephosphoryla-
tion of PEP to pyruvate) [50]. Only 47.4% of the G6P con-
tinues along the glycolytic path, while 51.1% enters the
pentose phosphate pathway (PPP). The remaining 1.5% is
converted to glucose 1-phosphate, of which 79.1% is used
to build glycogen, while the rest is consumed in several re-
actions of lipopolysaccharide biosynthesis. It should be
noted that much of the carbon that initially enters the PPP
returns to the glycolytic route via transaldolase and trans-
ketolase, respectively. Of the 66.0 mmol gDW−1 h−1 flux
of carbon atoms through G6P, 48.9 mmol gDW−1 h−1
(74.1%) reach PEP via glycolysis. The fluxes in the
whole PPP and its connections with glycolysis are shown
in Additional file 1: Figure S1.
Figure 2 shows the split ratios of acetate in its meta-
bolic context. Acetate is produced and secreted at the
Table 7 Split ratios of L-glutamate
Producing fluxes
Reaction/Enzyme Pathway/Product Ratio





GMP synthase purines 2.39%
CTP synthase CTP 1.57%






anthranilate synthase Trp 0.56%
Consuming fluxes
Reaction/Enzyme Pathway/Product Ratio
aspartate transaminase Asp 28.82%
glutamine synthetase Gln 17.57%
phosphoserine transaminase Ser 17.15%
L-alanine transaminase Ala 5.55%
leucine transaminase Leu 4.43%
valine transaminase Val 4.16%
succinyldiaminopimelate transaminase Lys, peptidoglycans 3.65%
N-acetylglutamate synthase Arg, polyamines 3.31%
acetylornithine transaminase Arg, polyamines 3.31%
isoleucine transaminase Ile 2.85%
Biomass 2.59%
glutamate 5-kinase Pro 2.17%
phenylalanine transaminase Phe 1.82%
tyrosine transaminase Tyr 1.36%
histidinol-phosphate transaminase His 0.93%
glutamate racemase peptidoglycans 0.28%
glutamyl-tRNA synthetase cobalamin, heme 0.05%
Total flux: 8.46 mmol gDW−1 h−1. Ratios below 0.05% not shown.
Abbreviations: Ala, Arg, … – biosynthesis of L-amino acids.
Table 6 Split ratios of 2-oxoglutarate
Producing fluxes
Reaction/Enzyme Pathway/Product Ratio
aspartate transaminase Asp 29.99%
isocitrate dehydrogenase TCA cycle 22.96%
phosphoserine transaminase Ser 17.85%
L-alanine transaminase Ala 5.78%
leucine transaminase Leu 4.61%
valine transaminase Val 4.33%
succinyldiaminopimelate transaminase Lys, peptidoglycans 3.80%
acetylornithine transaminase Arg, polyamines 3.45%
isoleucine transaminase Ile 2.97%
phenylalanine transaminase Phe 1.89%
tyrosine transaminase Tyr 1.41%
histidinol-phosphate transaminase His 0.97%
Consuming fluxes
Reaction/Enzyme Pathway/Product Ratio
glutamate dehydrogenase Glu 88.48%
2-oxoglutarate dehydrogenase TCA cycle 11.51%
Total flux: 8.12 mmol gDW−1 h−1. Ratios below 0.05% not shown.
Abbreviations: Ala, Arg, … – biosynthesis of L-amino acids.
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produced as a byproduct of arginine metabolism (4.4%),
L-cysteine biosynthesis (3.3%), and the biosynthesis of li-
popolysaccharides (0.2%), the largest part (92.1%) is pro-
duced from acetyl-CoA via phosphotransacetylase and
acetate kinase. At this rate of acetate secretion, more than
50% of all acetyl-CoA takes the acetate-exporting route in-
stead of the TCA cycle. FVA was used to verify that indeed
the forced acetate secretion is the sole reason for activity
in this route: If this constraint is disabled, acetate kinase
and phosphotransacetylase work in the opposite direction
to salvage the acetate produced as a byproduct of the
other pathways. FVA also confirmed that this route is the
cheapest way with regard to biomass yield to produce
acetate at the required rate.
Metabolic cycles and metabolite pools
Branch point analysis permits the visualisation of whole
pathways with actual fluxes. This is particularly useful
for metabolic cycles and metabolite pools that are
depleted and replenished via many different reactions.
Figure 3 shows all fluxes in the TCA cycle in the sce-
nario under consideration.
As mentioned above, only about one-sixth of the acetyl-
CoA enters the TCA cycle, while the majority is converted
to acetate for secretion. All the flux entering citrate syn-
thase also goes through isocitrate dehydrogenase, i.e. all
the citrate is converted to 2-oxoglutarate, which is the first
of two major branch points towards anabolic pathways. Asdescribed above, only 50.1% of the 2-oxoglutarate con-
tinues in the TCA cycle, forming succinyl-CoA. All of the
succinyl-CoA is eventually converted to succinate, 52.7%
within the TCA cycle, 33.0% in L-lysine biosynthesis, and
14.3% in the biosynthesis of L-methionine. All of the suc-
cinate is then oxidized to fumarate, but succinate dehydro-
genase is not the sole source of fumarate. Virtually all of
the fumarate is converted to oxaloacetate via fumarase
and malate dehydrogenase, but the largest part of the oxa-
loacetate (58.1%) results from the anaplerotic reaction
catalysed by PEP carboxylase.
Oxaloacetate is the second major branch point of the
TCA cycle. 56.6% of the flux through this node is
redirected towards anabolism, forming L-aspartate as the
first step. However, branch point analysis revealed the




glutamate dehydrogenase TCA cycle 100%
Consuming fluxes
Reaction Pathway Ratio
N-acetylglutamate synthase Arg, polyamines 30.10%
glutamine synthetase Gln 23.51%
Biomass 23.51%
glutamate 5-kinase Pro 19.75%
glutamate racemase peptidoglycans 2.54%
glutamyl-tRNA synthetase cobalamin, heme 0.49%
dihydrofolate synthase folate metabolism 0.08%
Total flux: 0.93 mmol gDW−1 h−1. Ratios below 0.05% not shown.
Abbreviations: Arg, Gln, Pro – biosynthesis of L-amino acids.
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http://www.biomedcentral.com/1752-0509/7/33presence of a cycle between oxaloacetate and fumarate
(shown in Figure 4). In this cycle, which carries a flux of
0.87 mmol gDW−1 h−1, L-aspartate formed from oxaloace-
tate transfers its amino group to different acceptors in
purine and arginine metabolism, respectively, yielding fu-
marate, which is converted back to oxaloacetate in the
TCA cycle. Correcting for this cycle yields a ratio of 54.3%
of oxaloacetate remaining in the cycle and 45.7% entering
anabolic pathways. The fraction of anaplerotic oxaloace-
tate (produced by PEP carboxylase) increases to 72.8%
with this correction.
While the predicted fraction of acetyl-CoA converted to
acetate (54%) is close to the value determined by Fischer
et al. [49] (55–59%), the fraction predicted to enter the
TCA cycle is considerably lower (17% vs. 25–30%). The
measured fluxes in the TCA cycle are almost twice as highFigure 1 Split ratios of glucose 6-phosphate and adjacent nodes. Gre
nodes are total flux in mmol gDW−1 h−1. Edge labels are split ratios as fracas the predicted ones – for instance, the flux through
isocitrate dehydrogenase was measured to be 27–33% of
the glucose uptake rate, while the predicted value is 17%.
In the alternative scenario with a forced transhydrogenase
flux of 5 mmol gDW−1 h−1, the flux through the TCA cycle
is considerably larger (isocitrate dehydrogenase: 2.9 vs. 1.9
mmol gDW−1 h−1), which is much closer to experimental
observations – 2.9 mmol gDW−1 h−1 amounts to 26% of
the glucose uptake rate of 11 mmol gDW−1 h−1. As a result,
the fraction of NADH produced via the TCA cycle in-
creases from 8.1% to 12.9%.
5,6,7,8-Tetrahydrofolate (THFA), via its activated
forms 5,10-methylene-THFA, 5-methyl-THFA, and 10-
formyl-THFA, is one of the cell’s most important donors
of one-carbon groups. In addition, it can act as a redu-
cing agent. Figure 5 shows all fluxes within the folate-
dependent one-carbon pool.
The total flux through THFA is 0.98 mmol gDW−1 h−1,
but only 0.08% of this stems from de-novo synthesis, while
most of the THFA circulates. Almost all of the THFA is
converted to 5,10-methylene-THFA, where the transferred
methylene group stems from cleavage of either L-serine
(94.8%) or glycine (4.9%). 0.23% is converted to 10-formyl
-THFA instead, reassimilating formate at the cost of ATP
hydrolysis. The largest part of the 5,10-methylene-THFA
(84.0%) is also subsequently converted to 10-formyl-THFA,
which transfers a formyl group in two reactions in the bio-
synthesis of purine nucleotides. 13.8% of the 5,10-methy-
lene-THFA is converted to 5-methyl-THFA, which donates
a methyl group in the biosynthesis of L-methionine. An-
other 2.2% is consumed in the biosynthesis of dTMP, where
it donates both a methylene group and two electrons,
resulting in dihydrofolate as the depleted form, which is
subsequently reduced back to THFA. Finally, 5,10-methy-
lene-THFA transfers a methylene group in the first step ofen: Metabolite nodes, yellow: enzyme nodes. Numbers in metabolite
tions of the flux through the adjacent metabolite node.
Figure 2 Split ratios of acetate and adjacent nodes. Green: Metabolite nodes, yellow: enzyme nodes. Numbers in metabolite nodes are total
flux in mmol gDW−1 h−1. Edge labels are split ratios as fractions of the flux through the adjacent metabolite node.
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total flux.
Essentiality of metabolite nodes
548 of the 557 metabolite nodes carrying a flux (98%) were
identified as essential for optimal growth by metabolite
flux minimisation. The remaining nine metabolites are
shown in Table 9, along with the number of reactions in
which they occur. As predicted by the model, they are in-
termediates in nonessential pathways. The results for theFigure 3 Metabolic fluxes and split ratios in the TCA cycle. Green: Met
are total flux in mmol gDW−1 h−1. Edge labels are split ratios as fractions ointracellular metabolites agree with the findings of Kim
et al. based on the earlier model iAF1260 [32]. However,
that study did not consider periplasmic or extracellular
metabolites. Menaquinone-8, which is involved in twenty-
three reactions, was identified as the most promiscuous
nonessential metabolite. While menaquinone-8 does not
carry a flux in the particular FBA solution used in this
work, FVA revealed that there are reactions involving
this metabolite that can carry a flux under the constraint
of optimal biomass production. Of the ten reactionsabolite nodes, yellow: enzyme nodes. Numbers in metabolite nodes
f the flux through the adjacent metabolite node.
Figure 4 Cycle between oxaloacetate and fumarate. Green: Metabolite nodes, yellow: enzyme nodes. Numbers in metabolite nodes are total
flux in mmol gDW−1 h−1. Edge labels are split ratios as fractions of the flux through the adjacent metabolite node.
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determined by FVA.
Adenosine and α-D-ribose 1-phosphate occur in a salvage
pathway for adenine, which can alternatively be converted
to AMP in one step via adenine phosphoribosyltransferase.
Fructose 1,6-bisphosphate can be completely bypassed in
the model by the sedoheptulose bisphosphate bypass, where
phosphofructokinase and fructose bisphosphate aldolase act
on sedoheptulose 7-phosphate from the pentose phosphate
pathway and sedoheptulose 1,7-bisphosphate instead
of fructose 6-phosphate and fructose 1,6-bisphosphate, re-
spectively. Since these pathways are stoichiometrically
equivalent, the use of either pathway allows optimal bio-
mass production. Periplasmic glycine is an intermediate
in a transport cascade that has the net effect of importing
Ca2+ ions. As the only Ca2+ importer available in the model
is a Ca2+/Na+ antiporter, a second transporter must be
active to pump Na+ ions to the cytosol. A large number of
Na+ symporters (including for glycine, glycolate, and acet-
ate) are present in the model, and most of these have the
same energy cost, as most of the used organic compounds
can be exported to the periplasm via 1:1 H+ symport.
Excess intracellular protons are exported to the extracellu-
lar space in our FBA solution. There exists a stoichiometric
alternative via a periplasmic ferroxidase, which produces
water from protons, oxygen, and electrons donated by Fe2+,
so that no protons are exported to the medium. The
additional import flux of Fe2+ required for the conversion
of all excess protons in this way is 14.0 mmol gDW−1
h−1, which is equal to the required Fe3+ export flux.Hydroxypyruvate occurs as an intermediate in the reaction
pair hydroxypyruvate isomerase + hydroxypyruvate reduc-
tase, which is stoichiometrically equivalent to the single re-
action catalysed by tartronate semialdehyde reductase.
Thioredoxin can be replaced by other reducing agents, as
the model contains alternative reactions to those catalysed
by thioredoxin-dependent enzymes.
The result that most active metabolite nodes are essen-
tial is complemented by the observation that according to
FVA, only 76 of the 552 active reactions (14%) are nones-
sential, i.e. most of the active reactions need to carry a flux
for optimal biomass production.
Table 10 shows the thirty-two intracellular metabolites
with the largest minimum turnover rates. Many entries in
this list are ubiquitous metabolites, such as H+, H2O, and
phosphate, or circulating currency metabolites or cofac-
tors, such as ATP/ADP, NADH/NAD+, and coenzyme A.
The list also contains a large number of glycolytic metabo-
lites, which is due to the high flux through glycolysis, as
all the carbon flux initially passes through glycolysis and
branches off to other pathways only gradually. Metabolite
flux minimisation also predicts large required fluxes
through O2 and CO2, which is expected for the aerobic
condition. Due to the transamination cycle described
above, L-glutamate and 2-oxoglutarate have high mini-
mum fluxes. Acetate and acetyl phosphate appear in the
list due to the high forced acetate export flux. In addition,
metabolites from the pentose phosphate pathway have to
carry a high flux, as that constitutes the cheapest way for
the model to produce NADPH.
Figure 5 Metabolite fluxes and split ratios within the tetrahydrofolate pool. Green: Metabolite nodes, yellow: enzyme nodes. Numbers in
metabolite nodes are total flux in mmol gDW−1 h−1. Edge labels are split ratios as fractions of the flux through the adjacent metabolite node.
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ranking is not by total flux, but by carbon flux, i.e. the
product of metabolite flux and number of carbon atoms
in the compound. The twenty intracellular non-cofactor
metabolites with the highest required carbon fluxes areTable 9 Metabolites carrying a flux but predicted to be
nonessential









[cell wall precursor of two linked disaccharide
pentapeptide and tetrapeptide murein units]
3
Shown is the number of reactions in which each nonessential metabolite
appears in the network.shown in Table 11. Half of these occur in glycolysis, and
another five are intermediates of the pentose phosphate
pathway. The remaining five metabolites in the list are
L-glutamate, 2-oxoglutarate, oxaloacetate (all involved in
transamination cycles), CO2, and acetate. The example
of glucose 6-phosphate illustrates the usefulness of this
alternative flux measure: It is only ranked eighth among
the carbon metabolites in Table 10 but is the most active
metabolite by carbon flux.
Discussion
We have demonstrated how the energy metabolism of
the cell, as predicted by the model, can be characterised
by compiling the balance sheets of a handful of currency
metabolites. The split ratios of currency metabolites can
be used to check a metabolic model for biological plausi-
bility even in the absence of specific experimental data for
the studied organism, as energy metabolism tends to fol-
low certain well-studied paradigms solely based on ecol-
ogy (phototrophic vs. chemotrophic, aerobic vs. anaerobic,
etc.). Thus, split-ratio analysis is a powerful tool for plausi-
bility checking and refinement of metabolic models.
Table 10 Intracellular metabolites with the largest minimum fluxes
Metabolite Minimum flux Metabolite Minimum flux
H+ 239.2 NADP+ 13.9
H2O 108.1 NADPH 13.9
ADP 69.7 pyruvate 13.3
ATP 69.7 coenzyme A 11.8
phosphate 66.9 glucose 6-phosphate 11.0
NAD+ 33.7 acetyl-CoA 10.8
NADH 33.7 ammonium 9.4
ubiquinol-8 33.0 L-glutamate 8.5
ubiquinone-8 33.0 dihydroxyacetone phosphate 8.2
CO2 23.5 2-oxoglutarate 8.1
glyceraldehyde 3-phosphate 17.8 fructose 6-phosphate 6.6
3-phospho-D-glycerate 17.7 acetate 6.4
1,3-bisphospho-D-glycerate 17.7 acetyl phosphate 5.9
O2 16.5 6-phospho-D-gluconate 5.6
2-phospho-D-glycerate 16.3 6-phospho-D-glucono-1,5-lactone 5.6
PEP 16.3 D-ribulose 5-phosphate 5.6
Shown is the minimum flux (in mmol gDW−1 h−1) that each metabolite has to carry for the growth rate to be maximal.
Table 11 Metabolites with the largest essential carbon fluxes
Metabolite C atoms Minimum flux Minimum C flux
glucose 6-phosphate 6 11 66
glyceraldehyde 3-phosphate 3 17.75 53.26
3-phospho-D-glycerate 3 17.75 53.24
1,3-bisphospho-D-glycerate 3 17.75 53.24
2-phospho-D-glycerate 3 16.3 48.89
PEP 3 16.3 48.89
L-glutamate 5 8.46 42.28
2-oxoglutarate 5 8.12 40.62
pyruvate 3 13.3 39.9
fructose 6-phosphate 6 6.59 39.55
6-phospho-D-gluconate 6 5.62 33.7
6-phospho-D-glucono-1,5-lactone 6 5.62 33.7
D-ribulose 5-phosphate 5 5.62 28.08
dihydroxyacetone phosphate 3 8.23 24.68
CO2 1 23.5 23.5
acetyl-CoA 2* 10.82 21.64
oxaloacetate 4 4.3 17.21
D-xylulose 5-phosphate 5 3.09 15.47
acetate 2 6.4 12.8
D-ribose 5-phosphate 5 2.5 12.5
Fluxes are in mmol gDW−1 h−1. *discounting CoA moiety.
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http://www.biomedcentral.com/1752-0509/7/33By inspecting selected metabolites in detail, we have
demonstrated how branch point analysis can be used to
elucidate the metabolic roles of compounds occurring in
the network in the scenario under consideration. For in-
stance, branch point analysis can be used to determine
whether a metabolite carrying a flux acts as a mere path-
way intermediate, is produced solely as a biomass com-
ponent, acts as energy or redox carrier, acts as a group
donor, or occurs as a mere byproduct, which is recycled
to central metabolism.
Split ratio analysis can also be used in an exploratory ap-
proach, as the relevant context for interpreting the flux
through any reaction is provided by its split ratios with re-
spect to the flux sums in each of the substrates and prod-
ucts involved. Branch point analysis presents just this
context at a glance. To revisit the questions posed in the
Background section: The flux through glutamate dehydro-
genase is easily interpretable when expressed as a fraction
of the total producing glutamate flux, the total consuming
2-oxoglutarate flux, the total consuming NADPH flux,
and possibly the total ammonia-consuming flux. Likewise,
the flux through aspartate transaminase is best expressed
as a fraction of the total fluxes through oxaloacetate, as-
partate, glutamate, and possibly 2-oxoglutarate.
Key split ratios, such as those of 2-oxoglutarate and oxa-
loacetate, can be used to identify the relative contributions
of a pathway to energy generation and biomass produc-
tion, respectively. Hence, a metabolite-centric view on flux
distributions can guide metabolic engineering, where the
goal is often to optimise split ratios between pathways
leading to product formation, biomass production, and
energy generation in order to achieve maximum product
yield [51,52]. In fact, if enzymes in a pathway producing a
desired product are overexpressed, the effect is not only
an increased flux through this pathway, but also a shift in
split ratios, as all matter entering the product-forming
route is diverted from energy and growth metabolism.
It should be noted that only a small fraction of the
metabolites in the network are branch points in any
given scenario, so that the global network behaviour can
be characterised via a small number of detailed analyses.
By reducing the metabolic network to only those
nodes that are branch points, branch point analysis al-
lows the visualisation of all fluxes within a metabolic
cycle, a metabolite pool, or even larger subsystems, as
we have demonstrated using the examples of the TCA
cycle, the folate-dependent one-carbon pool, and the
superpathway consisting of glycolysis and the pentose
phosphate pathway. Using advanced graph layouting al-
gorithms (possibly guided by a manually drawn pathway
map), it may even be possible to produce a clear and
informative visualisation of the steady-state fluxes in
the whole network. In addition, branch point analysis
allows the graphical identification of metabolic cycles,which can subsequently be analysed for their bio-
logical significance.
The system-wide analysis of branch points and split ra-
tios is complemented by metabolite essentiality analysis,
implemented using either flux-sum analysis or metabolite
flux minimisation. It should be noted that this type of ana-
lysis is only possible within a metabolite-centric view. For
instance, merely examining the fluxes or flux variabilities
of the twenty-three reactions in the E. coli model involving
menaquinone-8 or the ten reactions involving thioredoxin
cannot reveal these metabolites to be nonessential for op-
timal growth. In the case of thioredoxin, seven of the ten
fluxes can actually carry a flux under the constraint of op-
timal biomass production.
In metabolite flux minimisation, a nonessential metabol-
ite is identified as a metabolite with a minimum flux sum
of zero under the constraint of optimal biomass flux. In
flux-sum analysis, in contrast, a nonessential metabolite is
one that can be removed from the network (modelled by
restricting the fluxes consuming the metabolite to zero)
without a decrease in biomass flux [32]. The two defini-
tions are obviously equivalent. However, as metabolite flux
minimisation only alters the objective function and not
the constraints defining the solution space, it is amenable
to the same strategy that is used for speeding up FVA [53]
and, thus, is more computationally efficient.
Applying the metabolite-centric view introduced here
to the published model iJO1366 of E. coli, we discovered
a number of hitherto not discussed peculiarities in net-
work behaviour:
A systematic analysis of the balance sheets of all en-
ergy metabolites revealed unexpectedly strong activity of
dihydroxyacetone kinase, which further led to the dis-
covery of the high activity of fructose-6-phosphate (F6P)
aldolase in the FBA solution. Usually, F6P is phosphory-
lated once more to fructose 1,6-bisphosphate, and only
that is cleaved (into glyceraldehyde 3-phosphate and di-
hydroxyacetone phosphate). F6P aldolase was discovered
in E. coli in 2000 [54], but its function in vivo remains
obscure. Moreover, nothing is known about in-vivo ex-
pression of this enzyme. Schürmann and Sprenger [54]
note that the F6P cleavage reaction is 10 kJ mol−1 more
endergonic than the fructose-1,6-bisphosphate cleavage
reaction, making it unlikely for the reaction to proceed
in the cleavage direction rather than the reverse direction.
The central role, tight regulation, and ubiquitous prese-
nce of fructose-bisphosphate aldolase in the glycolytic
pathways of all organisms capable of classical (Embden-
Meyerhof-Parnas) glycolysis sheds further doubt on a
notable alternative being active in E. coli. While the
two reaction pairs F6P kinase + fructose-bisphosphate al-
dolase and F6P aldolase + dihydroxyacetone kinase are
stoichiometrically equivalent except for the phosphorylat-
ing agent involved (ATP vs. PEP), the model would likely
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the flux through F6P aldolase were constrained so as to
disallow the cleavage direction. Possibly, the reaction
should even be omitted altogether until more is known
about in-vivo expression and regulation of the enzyme.
The inclusion of F6P aldolase in the model (which is not
discussed by the authors of iJO1366 or either of its prede-
cessors iAF1260 and iJR904) may represent a case of a
spurious enzyme function, possibly resulting from blanket
inclusion of all enzymes found in an automated database
search. If added with unconstrained flux, such cryptic en-
zymes can dramatically lower the quality of the predic-
tions made by the model.
A systematic survey of metabolite essentiality resulted in
the equally surprising observation that in the model, fruc-
tose 1,6-bisphosphate is nonessential for optimal growth.
The reason was found in the sedoheptulose bisphosphate
bypass, which is equivalent to the standard reactions of
phosphofructokinase and fructose bisphosphate aldolase
with regard to biomass flux. Notable activity in this path-
way has, however, only been observed in transaldolase-
deficient mutants, but never in wild-type strains of E. coli
[46]. It is likely that the affinities of these enzymes to the
respective sedoheptulose phosphates are much lower than
to the corresponding fructose phosphates, so that in vivo,
the bypass reactions would not be expected to display
significant activity unless there is an accumulation of
sedoheptulose 7-phosphate for some reason. Therefore, it
would be advisable to constrain the fluxes through the by-
pass reactions to zero when specifically studying the wild-
type network.
We found a strong discrepancy between the predicted
NADPH balance and that measured in [48]. This dis-
crepancy is explained by the fact that in vivo, a more
costly reaction (proton-translocating transhydrogenase)
accounts for a substantial fraction of the NADPH pro-
duced. Flux through this reaction reduces the number of
protons in the periplasm available to ATP synthase,
which means that more carbon has to be respired to
CO2, lowering the biomass yield. Therefore, this reaction
is not used for the generation of NADPH in an FBA flux
distribution optimised for biomass production. To im-
prove the capability of the model to predict fluxes in
‘aerobic growth on sugars’ scenarios, a flux through this
reaction needs to be enforced, as we could show in
preliminary tests with altered simulation parameters.
Ideally, this should be done by postulating a stoichio-
metric coupling to one or more other reactions instead
of fixing the flux at an absolute value. For instance, a
constant ratio of periplasmic protons might be forced to
take this route, resulting in a stoichiometric coupling to
ATP synthase. Or, if that should reproduce experimental
results more faithfully, the flux through this reaction
could be coupled to the fluxes through other NADPH-producing reactions. In the absence of new experimental
data, a black-box approach could also be taken, where
the transhydrogenase flux would be set to a fixed frac-
tion of the carbon flux entering the system. Of course,
the ratio between NADPH-producing reactions may
change dramatically depending on carbon source and
availability of oxygen, so that any such constraints are
only valid for the particular scenario of carbon-limited
aerobic growth on sugars.
In the original scenario, the predicted flux going through
the TCA cycle (~ 1.9 mmol gDW−1 h−1) is very low in
comparison to those through acetyl-CoA (10.8 mmol
gDW−1 h−1) and PEP (16.3 mmol gDW−1 h−1). In addition,
the anabolic fluxes branching from the TCA cycle are very
large (50.1% of 2-oxoglutarate and 45.7% of oxaloacetate).
Taken together, these results indicate that in the original
scenario, the primary purpose of the TCA cycle, as pre-
dicted by the model, is not energy generation but produc-
tion of C5 and C4 compounds for the biosynthesis of
biomass components. This can also be seen in the low
contribution of the TCA cycle to NADH and NADPH
production. When adding a flux through proton-
translocating transhydrogenase of 5 mmol gDW−1 h−1, the
role of the TCA cycle shifts somewhat from the produc-
tion of biomass precursors towards energy metabolism, as
the fraction of NADH produced via the TCA cycle in-
creases from 8.1% to 12.9%. This is also reflected in the
lowered fractions of 2-oxoglutarate (31% vs. 50%) and oxa-
loacetate (35% vs. 46%) branching from the TCA cycle to-
wards anabolic pathways.
Metabolite flux minimisation revealed a potential prob-
lem in the model by predicting that flux through extracel-
lular protons is not essential for optimal growth: Excess
intracellular protons, which are transported to the peri-
plasm via the complexes of the electron transfer chain,
can be converted to water by ferroxidase in the periplasm
instead of being exported through the outer membrane.
The electrons required for the involved reduction of
molecular oxygen are donated by Fe2+, which has to be
imported at an extreme rate of 14 mmol gDW−1 h−1,
which is equivalent to 0.8 grams of iron per gram dry
weight per hour. This is obviously unrealistic, especially as
the produced Fe3+ has a low solubility at neutral pH [55].
The only reason why the free import of electrons resulting
from the free import of Fe2+ does not have more pro-
nounced effects on the model as a whole is that it is lim-
ited to the periplasm, i.e. these electrons cannot be used to
perform work in the cytosol. To limit the flux through the
ferroxidase reaction, the secretion rate of Fe3+ should be
restricted to zero (or a value close to zero).
We demonstrated the ability of split-ratio analysis and
branch point analysis to assign metabolic roles. These
roles are often in agreement with long-established know-
ledge of metabolic pathways, but in other cases it
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modified in different contexts and that the metabolism
is highly flexible in making use of different capabilities
many metabolites provide.
In the small number of discussed examples, the role of
L-glutamine, L-glutamate, and L-aspartate as amino-
group donors became obvious. Furthermore, the forced
acetate secretion flux was shown to be responsible for
more than 90% of the total acetate-producing flux.
Thioredoxin was predicted to be redundant in steady-
state metabolism despite being involved in ten reactions
in the network. This prediction is in agreement with the
observation that trxA trxC double mutants of E. coli are
phenotypically inconspicuous [56]. However, thioredoxins
may be essential for the oxidative stress response [57],
which is an inherently non-steady-state process and thus
cannot be studied using FBA.
It should be noted that the transformation of reaction
fluxes to metabolite fluxes and split ratios and the com-
putational methods introduced here are applicable to
any flux distribution, whether computationally pre-
dicted or experimentally determined, e.g. via 13C tracer
analysis. The only requirement is a flux distribution at
the resolution of individual reactions rather than
summed “pathway fluxes”.Conclusions
This paper introduces a new, metabolite-centric view on
flux distributions in genome-scale metabolic networks.
We have shown how a metabolite-centric view on flux dis-
tributions opens the door to a more detailed analysis than
is possible within the traditional reaction-centric frame-
work. Split-ratio analysis and its extension branch point
analysis facilitate the interpretation of flux distributions by
providing metabolic context.
Within a metabolite-centric view, it is very easy to
simultaneously analyse all fluxes in a metabolic context,
as demonstrated here for the full metabolic contexts of
energy metabolism, the TCA cycle, the interconnected
transamination cycles, the superpathway of glycolysis
and the pentose phosphate pathway, and the folate-
dependent one-carbon pool. This contextualisation
leads to new biological interpretations not apparent
from isolated reaction fluxes, which can be used for val-
idating and refining the model’s predictive capabilities
for specific growth scenarios.
In summary, switching from a reaction-centric to a
metabolite-centric view on flux distributions allows a
wealth of inferences to be drawn that are not apparent from
the reaction fluxes alone. The computational methods we
have introduced here allow the analysis of reaction fluxes,
whether predicted or determined experimentally, in context
rather than in isolation.Methods
Metabolic model iJO1366
The genome-scale metabolic model iJO1366 covers 1366
open reading frames of Escherichia coli K-12 MG1655.
The reconstructed network comprises a total of 2583 reac-
tion nodes (including transport and exchange reactions and
two artificial reactions modelling the formation of biomass)
and 1805 metabolite nodes (1039 cytoplasmic, 442 periplas-
mic, 324 extracellular). The model was downloaded from
the supplementary material of the corresponding publica-
tion [10] in the SBML format [58].
iJO1366 is a stoichiometric model, which is mathem-
atically represented by a stoichiometric matrix S and a
set of lower and upper flux bounds lb ≤ v ≤ ub
constraining the flux variables v [59]. S is an m × n
matrix, where m is the number of metabolites (1805), n
is the number of reactions in the network (2583), and v
is an n × 1 vector. The entry sij of S is the stoichiometric
coefficient of metabolite i in reaction j. It is positive if
metabolite i occurs on the right-hand side of reaction j,
negative if it occurs on the left-hand side, and zero if it
is not involved in the reaction. The flux bounds {lb, ub}
represent, inter alia, thermodynamic constraints (e.g. ir-
reversibility of reactions) and medium properties (e.g.
constraining the uptake of a compound not present in
the medium to zero).
Important model parameters are the growth-associated
and non-growth-associated maintenance requirements (ab-
breviated as GAM and NGAM, respectively). The GAM is
part of the biomass reaction and models the ATP cost of
growth-associated processes, most importantly DNA, RNA,
and protein polymerisation, per gram dry weight, while the
NGAM is modelled as an ATP hydrolysis reaction with a
fixed flux and represents maintenance processes that
consume ATP but are not associated with growth [60].
These processes include, among others, DNA repair and
maintaining turgor pressure and membrane potential.
Flux balance analysis (FBA)
The fluxes through the network in steady state were com-
puted using flux balance analysis [16,61,62]. FBA is a math-
ematical method for predicting the flux distribution in a
stoichiometric network without requiring knowledge of in-
vivo kinetic parameters. Its underlying assumptions are
steady state and optimality. The first assumption, mathem-
atically expressed as Sv = 0, is that the system is in a flux
equilibrium with all metabolite concentrations constant
[63]. The second assumption is that the organism has been
optimised through its evolutionary history for some bio-
logical goal [17], usually biomass production (growth).
We used the implementation of FBA in metano, the
open-source software toolkit developed in our group
(Riemer et al., manuscript in preparation). The software
is written in the Python programming language and is
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implementation by comparing our solutions for the earlier
model iAF1260 to the corresponding published FBA solu-
tions [11], using identical simulation parameters in two dif-
ferent scenarios (growth on glucose minimal medium;
scenario 1: glucose uptake rate 8 mmol gDW−1 h−1,
carbon-limited; scenario 2: glucose uptake rate 11 mmol
gDW−1 h−1, oxygen uptake rate 18.2 mmol gDW−1 h−1,
carbon- and oxygen-limited). Apart from alternate (but also
optimal) pathway usage, both FBA solutions could be
reproduced (data not shown).
Simulation parameters
For the analyses on the model iJO1366, the glucose uptake
rate was set to 11.0 mmol gDW−1 h−1, and acetate secretion
was added at a rate of 6.4 mmol gDW−1 h−1. These values
were reported in [49] for exponential growth in a bioreac-
tor, the scenario that corresponds best to the infinite envir-
onment assumed implicitly in FBA. Moreover, the specific
constraints described in [11] for aerobic growth on glucose
were employed. These include blocking reactions that are
not active in this scenario and fixing the effective proton
translocation rate for the NADH dehydrogenase complex
at 1.5 protons per molecule of NADH. The latter is equiva-
lent to setting the ratio between proton-translocating and
non-proton-translocating NADH dehydrogenase to 1:1. The
metano input files for this scenario and the resulting output
files are provided in Additional files 2 and 3, respectively.
A second scenario, which was derived from the one
described above by adding a forced flux of 5 mmol
gDW−1 h−1 through proton-translocating transhydrogenase,
was employed in an attempt to resolve discrepancies found
initially between model predictions and experimental data.
Flux variability analysis (FVA)
The solutions returned by FBA are not necessarily unique,
as for whole-genome models, the objective function usu-
ally assumes the optimum at more than one point in the
solution space [60]. Flux variability analysis successively
minimises and maximises each flux variable under the
additional constraint of an optimal or suboptimal objective
function value [64], thus exploring the shape of the opti-
mal solution space. In the present study, FVA was used to
test whether reported fluxes or split ratios must necessar-
ily assume the values predicted by FBA or if there are al-
ternate optimal solutions. FVA has been implemented in
metano in the ‘fast FVA’ variety of the algorithm [53].
Split-ratio analysis
We developed the following algorithm to compute me-
tabolite fluxes and split ratios from reaction fluxes:
Given a stoichiometric matrix S and a flux vector v,
For each metabolite i:1. Compute partial fluxes ρij = sij · vj for all reactions j
and group into positive (producing) and negative
(consuming):
Pi ¼ j ρij > 0














Φi is the total flux through metabolite i (or flux sum, as de-
fined in [32]), and the ρij are the split ratios of metabolite i,
which are again grouped by sign (producing or consuming)
and expressed as percentages of Φi. More precisely, ρij is
the fraction of metabolite i produced (if positive) or con-
sumed (if negative) via reaction j.Branch point analysis
Branch point analysis was developed to generalise the ap-
proach of split-ratio analysis to the whole metabolic net-
work and visualise the extended metabolic context of a
selected metabolite or reaction. The analysis starts with
the complete bipartite reaction graph, which consists of all
reactions and metabolites that are active in the given FBA
solution (i.e. carry a flux above some threshold). As the
complete graph is much too complex for a meaningful in-
terpretation, the graph is reduced according to user-
supplied parameters.
The user selects a node (i.e. reaction or metabolite) as
the hub of the analysis. Optionally, the user can provide a
list of nodes to be excluded and a list of nodes to be dis-
connected. Excluded nodes are completely removed from
the graph, while disconnected nodes are split into separate
instances for each occurrence of the metabolite or reaction
in the network. Typically, the first list would be used to
exclude metabolites that are ubiquitous, but in most con-
texts uninteresting to the user (e.g. H2O or H
+). The sec-
ond list can be used to prevent crowding of the graph by
promiscuous compounds such as currency metabolites
(e.g. ATP or NADH). Finally, the user can specify a max-
imum distance to the selected hub node. Nodes beyond
this limit will not be shown in the final graph.
It is possible to select more than one hub for the analysis,
which allows fine-grained selection of nodes for inclusion
and exclusion. However, if the resulting graph is discon-
nected, only the largest connected component is displayed.
The algorithm is illustrated schematically in Figure 6.
Branch point analysis starts with the calculation of the
Figure 6 Sequence of example graphs demonstrating the algorithm of branch point analysis. Node R1 has been selected as hub, node X
is to be disconnected, and Y is to be removed. The configured maximum distance from the selected node is two. A) Initial bipartite graph.
B) Disconnection (X) or removal (Y), respectively, of selected nodes. C) Bridging of transitory nodes (B, R2, C). D) Removal of all nodes with a
distance greater than two from the hub, R1. E) Condensed metabolic context of reaction R1 produced by branch point analysis.
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distribution. Subsequently, the bipartite reaction graph is
built, and the edges are labelled with their corresponding
split ratios (as percentage of the flux through the adjacent
metabolite node). Figure 6A shows the initial state of an
example graph representing the metabolic context of reac-
tion R1, with edge labels omitted for clarity. Next, the re-
spective nodes specified by the user are removed and
disconnected (Figure 6B). At this point, the complexity of
the graph is further reduced by bridging transitory nodes
(Figure 6C). Specifically, each node that has exactly two
neighbours is replaced by a dashed edge. This step is ap-
plied iteratively until no such nodes remain. Disconnected
nodes are not taken into account when the number of
neighbours is determined. Finally, all nodes beyond the
specified maximum distance are removed (Figure 6D). Be-
sides the selected node, the remaining graph contains only
nodes at which the metabolic flux branches – metabolic
branch points (Figure 6E).
We implemented branch point analysis in the Python
programming language based on metano. The resulting
program, AMEBA (Advanced MEtabolic BranchpointAnalysis), is distributed under the GNU General Public Li-
cense version 3 and can be downloaded from http://
metano.tu-bs.de/ameba. Our implementation uses
NetworkX [65] for graph operations and Graphviz [66] for
graph layouting. An interactive mode has been
implemented using the xdot module (http://code.google.
com/p/jrfonseca/wiki/XDot).
Metabolite flux minimisation
The following algorithm was used to determine the mini-
mum flux that each metabolite node has to carry under
the constraint of (sub)optimal biomass production:
1. Split flux variables into positive and negative
components:
vj ¼ vþj −v−j ; where vþj ≥0 and v−j ≥0;
and duplicate and negate the corresponding columns
of the stoichiometric matrix S. The result is a vector
of non-negative flux variables. Lower and upper
bounds have to be adjusted accordingly. In practice,
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along with the corresponding columns of S.
2. Using the modified flux vector and stoichiometric
matrix from step 1:











in steady state: Sv = 0
with inequality constraints lb ≤ v ≤ ub
and the additional constraint:
vBiomass ≥ ζ : vBiomass;opt with 0 < ζ≤1:
In effect, this algorithm successively minimises each of
the producing metabolite flux sums Φi. The optimisation
problems were solved using the GNU Linear Program-
ming Kit (GLPK; www.gnu.org/software/glpk/glpk.html).
As metabolite flux minimisation is very similar to FVA,
the ‘fast FVA’ strategy is applicable to this algorithm as
well, and it has been implemented in metano with this
performance optimisation. In this study, metabolite flux
minimisation was used for identifying nonessential me-
tabolites and for determining minimal metabolite turn-
over rates Φi.
Additional files
Additional file 1: Figure S1. Metabolite fluxes and split ratios within
the superpathway of glycolysis and the pentose phosphate pathway.
Green: Metabolite nodes, yellow: enzyme nodes. Numbers in metabolite
nodes are total flux in mmol gDW−1 h−1. Edge labels are split ratios as
fractions of the flux through the adjacent metabolite node.
Additional file 2: Metano input files generated from model
iJO1366. Model and scenario file – see http://metano.tu-bs.de/quickref.
html for description of file formats.
Additional file 3: Metano output files (FBA, FVA, split-ratio
analysis). See http://metano.tu-bs.de/quickref.html for description of file
formats.
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